Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Estimation and prediction of drug therapy on the termination of atrial fibrillation by autoregressive model with exogenous inputs.

Kuo CE, Liang SF, Lu SS, Kuan TC, Lin CS.

IEEE J Biomed Health Inform. 2013 Jan;17(1):153-61. doi: 10.1109/TITB.2012.2224877.

PMID:
23144042
2.

Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.

Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S.

Circulation. 1993 Sep;88(3):1030-44.

PMID:
8353865
3.

Influence of propafenone on resetting and termination of canine atrial flutter.

Mensour B, Jalil E, Vinet A, Kus T.

Pacing Clin Electrophysiol. 2000 Aug;23(8):1200-19.

PMID:
10962741
4.

Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.

Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.

Am J Cardiol. 2001 Sep 15;88(6):640-5.

PMID:
11564387
6.

Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.

Milberg P, Frommeyer G, Ghezelbash S, Rajamani S, Osada N, Razvan R, Belardinelli L, Breithardt G, Eckardt L.

Europace. 2013 May;15(5):761-9. doi: 10.1093/europace/eus399.

PMID:
23376977
7.

Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation.

Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Chen YJ, Yu WC, Huang JL, Fong AN, Cheng JJ, Chang MS.

Am J Cardiol. 1997 Apr 1;79(7):905-8.

PMID:
9104904
8.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

9.

Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.

Osaka T, Yamazaki M, Yokoyama E, Ito A, Kodama I.

J Cardiovasc Electrophysiol. 2004 Aug;15(8):877-84.

PMID:
15333078
10.

Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.

Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL.

J Cardiovasc Electrophysiol. 2009 Jul;20(7):796-802. doi: 10.1111/j.1540-8167.2009.01437.x.

PMID:
19298570
12.

Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.

Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.

J Am Coll Cardiol. 2004 Aug 18;44(4):859-63.

13.

Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity.

Iwasa A, Okumura K, Tabuchi T, Tsuchiya T, Tsunoda R, Matsunaga T, Tayama S, Yasue H.

Eur J Pharmacol. 1998 Aug 28;356(1):31-40.

PMID:
9761421
14.
15.

Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline.

Hoekstra BP, Diks CG, Allessie MA, DeGoede J.

Arch Physiol Biochem. 2000 Oct;108(4):332-48.

PMID:
11094385
16.

Effects of intrapericardial sotalol and flecainide on transmural atrial electrophysiology and atrial fibrillation.

van Brakel TJ, Hermans JJ, Accord RE, Schotten U, Smits JF, Allessie MA, Maessen JG.

J Cardiovasc Electrophysiol. 2009 Feb;20(2):207-15. doi: 10.1111/j.1540-8167.2008.01318.x.

PMID:
19175851
17.

Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.

N Engl J Med. 2000 Mar 30;342(13):913-20.

18.

Spatial correlation analysis of atrial activation patterns during sustained atrial fibrillation in conscious goats.

Hoekstra BP, Diks CG, Allessie MA, DeGoede J.

Arch Physiol Biochem. 2000 Oct;108(4):313-31.

PMID:
11094384
19.
20.

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.

Savelieva I, Camm J.

Europace. 2008 Jun;10(6):647-65. doi: 10.1093/europace/eun130. Review.

PMID:
18515286

Supplemental Content

Support Center